Effect of chronic administration of carvedilol, 6.25mg to 25mg b.i.d., on renal hemodynamics in mild to moderate essential hypertension.

Study Complete

Last updated: 11/03/2018 05:50:57

GSK Study ID:

101468/004

See Study Documents Below

ClinicalTrials.gov Identifier:

Not Applicable

EudraCT Number:

Not Applicable

EU CT Number:

Not Applicable

Study Overview

Clinical Trial Medical Condition and Disease

Medical Condition(s)

Parkinson Disease

Clinical Trial Medical Condition and Disease

Product

ropinirole

Clinical Trial Medical Condition and Disease

Collaborators

N/A

Clinical Trial Medical Condition and Disease

Date

To

Clinical Trial Medical Condition and Disease

Type

N/A

Clinical Trial Phases

Phase

1

Clinical Trial Gender and Sex Female and Male

Sex

N/A

Clinical Trial Age Range or Limit

Age

N/A

Clinical Trial Drug Treatment

Accepts Healthy Volunteers

N/A

Locations icon

No locations available.

Protocol Summary icon

Study Description:

Effect of chronic administration of carvedilol, 6.25mg to 25mg b.i.d., on renal hemodynamics in mild to moderate essential hypertension.

Primary Purpose:

Not Available

Allocation:

Not Available

Study Design:

Not Available

Masking:

Not Available

Primary Outcomesicon

Not Available

Secondary Outcomesicon

Not Available

Interventions:

    Not Available

Inclusion/Exclusion Criteria:

Inclusion Criteria

-

Exclusion Criteria

-

Enrollment:

Not Available

upBack to Top
BESbswy